文献速递眼整形与眼眶眼底病与葡萄膜炎

骨桥蛋白在Graves眼病发病机制中的潜在作用

The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

本研究检测了Graves眼病(GO)患者眶脂肪结缔组织中骨桥蛋白(OPN)的表达及其与相关细胞因子的关系,并观察OPN对眼眶成纤维细胞(OFs)增殖、迁移及相关细胞因子表达的影响。结果显示活动期GO患者OPN表达显著增高,且与CD40L和HAS2 mRNA水平正相关;OPN通过PI3K/Akt信号通路促进OFs增殖和迁移,并诱导VEGF和I型胶原mRNA表达。

要点

  • 活动期GO患者眶脂肪结缔组织中OPN mRNA和蛋白水平显著高于非活动期GO患者。
  • GO患者OPN mRNA水平与CD40L及HAS2 mRNA呈正相关。
  • OPN通过PI3K/Akt通路促进OFs增殖、迁移并诱导VEGF和I型胶原表达。

核心结论

  • OPN在活动期GO患者眶脂肪结缔组织中显著增高,且与CD40L和HAS2 mRNA水平相关。
  • OPN通过PI3K/Akt信号通路促进OFs增殖、迁移并诱导VEGF和I型胶原mRNA表达,提示其在GO发病中可能通过激活OFs发挥作用。

研究设计与样本

  • 获取24例GO患者(12例活动期,12例非活动期)和12例健康对照者的眶脂肪结缔组织。
  • 从活动期GO患者眶减压手术获得的眶组织中分离OFs。
  • 采用定量PCR和Western blot检测RNA和蛋白表达,MTT法和细胞划痕试验检测OFs增殖和迁移。
  • 应用OPN单克隆抗体1A12、ERK1/2抑制剂PD98059和PI3K抑制剂LY294002确定涉及的信号通路。

主要发现

  • 活动期GO患者眶脂肪结缔组织中OPN mRNA和蛋白水平较非活动期GO患者分别增高2.83倍(P < 0.001)和1.91倍(P < 0.05)。
  • GO患者OPN mRNA水平与CD40L和HAS2 mRNA呈正相关。
  • OPN促进OFs增殖和迁移速率,并诱导VEGF和I型胶原mRNA表达;这些效应被1A12或LY294002抑制。

临床怎么用

  • OPN可能作为活动期GO的潜在生物标志物或治疗靶点,但需进一步临床验证。
  • PI3K/Akt通路可能介导OPN对OFs的激活作用,为GO治疗提供新思路。

局限性

  • 样本量较小(24例GO患者和12例对照),结论需更大样本验证。
  • 研究为体外实验,OPN在GO中的体内作用机制尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study is to evaluate the expression of osteopontin (OPN) and its relationship with relative cytokines in patients with Graves' ophthalmopathy (GO), and to observe the effect of OPN on orbital fibroblasts (OFs) proliferation, migration, and the expression of relative cytokines, as well as the signaling pathways involved in its effect. METHODS: The orbital adipose connective tissue was obtained from 24 patients with GO (12 cases of active GO, and 12 cases of inactive GO) and 12 healthy controls. OFs were isolated from orbital tissues obtained from patients with active GO who were undergoing orbital decompression surgery. Quantitative PCR and Western blot were performed to detect RNA and protein expression. The proliferation and cell migration rates of OFs were measured by methylthiazol tetrazolium (MTT) and the cell scratch test. Signaling pathway inhibitors, such as OPN monoclonal antibody 1A12, ERK1/2 inhibitor PD98059, and PI3K inhibitor LY294002, were applied to determine the involved pathways. RESULTS: The mRNA and protein levels of OPN were increased in orbital adipose connective tissue from patients with active GO than those from patients with inactive GO (2.83-fold increase, P < 0.001; 1.91-fold increase, P < 0.05). The OPN mRNA level was positively correlated with CD40 ligand (CD40L) and hyaluronan synthases 2 (HAS2) mRNA in patients with GO. OPN promoted proliferation and migration rate of OFs and induced vascular endothelial growth factor (VEGF) and collagen I mRNA expression, and the effects were inhibited by 1A12 or LY294002. CONCLUSIONS: OPN in orbital adipose connective tissues were significantly increase in active GO, and there were significant correlations of OPN with CD40L and HAS2 mRNA levels in patients with GO. OPN promoted proliferation and migration of OFs and induced VEGF and collagen I mRNA expression in OFs through PI3K/Akt signaling pathway. This suggested a role for OPN in the pathogenesis of GO through the activation of OFs.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lou H, Wu LQ, Wang H, et al. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy. Invest Ophthalmol Vis Sci. 2021. PMID: 34546326. doi:10.1167/iovs.62.12.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。